tiprankstipranks
CANbridge Pharmaceuticals Inc. (HK:1228)
:1228
Hong Kong Market
1228
CANbridge Pharmaceuticals Inc.
RESEARCH TOOLSreports
Want to see HK:1228 full AI Analyst Report?

CANbridge Pharmaceuticals Inc. (1228) Ratios

0 Followers

CANbridge Pharmaceuticals Inc. Ratios

HK:1228's free cash flow for Q2 2025 was ¥0.69. For the 2025 fiscal year, HK:1228's free cash flow was decreased by ¥ and operating cash flow was ¥-1.88. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.24 0.24 0.09 0.64 1.82
Quick Ratio
 0.20 0.20 0.08 0.61 1.78
Cash Ratio
 0.15 0.15 0.02 0.38 1.62
Solvency Ratio
 -0.06 0.05 -0.73 -0.81 -1.17
Operating Cash Flow Ratio
 -0.02 -0.08 -0.25 -0.85 -1.01
Short-Term Operating Cash Flow Coverage
 -1.00 -5.44 -7.99 -11.74 -10.46
Net Current Asset Value
¥ -396.98M¥ -397.15M¥ -545.95M¥ -225.29M¥ 111.67M
Leverage Ratios
Debt-to-Assets Ratio
 0.10 0.10 1.16 0.36 0.22
Debt-to-Equity Ratio
 -0.05 -0.05 -0.29 -3.57 0.50
Debt-to-Capital Ratio
 -0.05 -0.05 -0.40 1.39 0.33
Long-Term Debt-to-Capital Ratio
 -0.02 -0.02 -0.03 -0.20 0.03
Financial Leverage Ratio
 -0.48 -0.48 -0.25 -9.94 2.28
Debt Service Coverage Ratio
 -8.79 -8.53 -13.75 -10.46 -13.48
Interest Coverage Ratio
 -29.13 -41.57 -39.67 -40.96 -66.73
Debt to Market Cap
 0.02 0.01 0.57 0.08 0.04
Interest Debt Per Share
 0.05 0.04 0.34 0.36 0.38
Net Debt to EBITDA
 0.55 0.64 -0.38 -0.05 0.65
Profitability Margins
Gross Profit Margin
65.69%73.28%63.81%62.37%61.91%
EBIT Margin
-241.73%-185.46%-400.12%-359.57%-603.52%
EBITDA Margin
-218.58%-161.15%-386.23%-331.90%-575.69%
Operating Profit Margin
-241.73%-185.46%-400.12%-356.32%-579.91%
Pretax Profit Margin
-90.65%29.65%-520.10%-368.26%-612.21%
Net Profit Margin
-90.65%29.65%-520.10%-368.26%-612.21%
Continuous Operations Profit Margin
-90.65%29.65%-520.10%-368.26%-612.21%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
37.50%-15.99%129.99%103.35%105.57%
Return on Assets (ROA)
-23.24%8.72%-378.91%-95.82%-68.87%
Return on Equity (ROE)
9.41%-4.22%93.28%952.14%-156.69%
Return on Capital Employed (ROCE)
35.35%31.13%93.09%-543.70%-108.03%
Return on Invested Capital (ROIC)
36.35%32.01%100.53%-358.86%-98.74%
Return on Tangible Assets
-34.73%13.04%-903.47%-118.81%-76.27%
Earnings Yield
-4.76%1.38%-834.08%-99.51%-52.68%
Efficiency Ratios
Receivables Turnover
 2.70 3.22 5.09 3.29 4.14
Payables Turnover
 0.04 0.04 0.08 0.20 0.28
Inventory Turnover
 0.71 0.63 3.90 4.41 3.06
Fixed Asset Turnover
 82.98 95.24 23.39 0.94 0.63
Asset Turnover
 0.26 0.29 0.73 0.26 0.11
Working Capital Turnover Ratio
 -0.10 -0.12 -0.31 1.89 0.19
Cash Conversion Cycle
 -8.60K -9.66K -4.22K -1.67K -1.10K
Days of Sales Outstanding
 135.43 113.39 71.72 110.80 88.07
Days of Inventory Outstanding
 516.01 577.35 93.66 82.82 119.22
Days of Payables Outstanding
 9.25K 10.35K 4.39K 1.87K 1.31K
Operating Cycle
 651.44 690.73 165.38 193.62 207.28
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.02 -0.08 -0.29 -0.66 -0.66
Free Cash Flow Per Share
 -0.02 -0.08 -0.29 -0.75 -0.74
CapEx Per Share
 <0.01 <0.01 <0.01 0.10 0.08
Free Cash Flow to Operating Cash Flow
 1.01 1.00 1.00 1.15 1.12
Dividend Paid and CapEx Coverage Ratio
 -154.90 -6.37K -1.17K -6.81 -8.08
Capital Expenditure Coverage Ratio
 -154.90 -6.37K -1.17K -6.81 -8.08
Operating Cash Flow Coverage Ratio
 -0.44 -2.38 -0.90 -1.96 -1.81
Operating Cash Flow to Sales Ratio
 -0.17 -0.78 -1.44 -2.70 -3.56
Free Cash Flow Yield
-0.88%-3.66%-230.84%-83.82%-34.41%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -21.01 72.25 -0.12 -1.00 -1.90
Price-to-Sales (P/S) Ratio
 19.04 21.42 0.62 3.70 11.62
Price-to-Book (P/B) Ratio
 -2.36 -3.05 -0.11 -9.57 2.97
Price-to-Free Cash Flow (P/FCF) Ratio
 -113.82 -27.29 -0.43 -1.19 -2.91
Price-to-Operating Cash Flow Ratio
 -114.56 -27.29 -0.43 -1.37 -3.27
Price-to-Earnings Growth (PEG) Ratio
 -0.23 -0.70 >-0.01 0.05 0.02
Price-to-Fair Value
 -2.36 -3.05 -0.11 -9.57 2.97
Enterprise Value Multiple
 -8.17 -12.65 -0.54 -1.16 -1.37
Enterprise Value
 756.95M 992.38M 178.34M 397.71M 621.84M
EV to EBITDA
 -8.17 -12.65 -0.54 -1.16 -1.37
EV to Sales
 17.85 20.38 2.10 3.87 7.87
EV to Free Cash Flow
 -106.71 -25.97 -1.46 -1.25 -1.97
EV to Operating Cash Flow
 -107.40 -25.97 -1.46 -1.43 -2.21
Tangible Book Value Per Share
 -0.93 -0.87 -1.28 -0.27 0.57
Shareholders’ Equity Per Share
 -0.80 -0.75 -1.12 -0.09 0.73
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.10 0.11 0.20 0.24 0.19
Net Income Per Share
 -0.09 0.03 -1.04 -0.89 -1.14
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 0.38 -0.16 1.30 1.02 1.01
Research & Development to Revenue
 1.35 0.89 2.96 2.50 3.94
SG&A to Revenue
 1.72 1.68 1.68 0.87 1.38
Stock-Based Compensation to Revenue
 0.12 0.10 0.09 0.19 0.34
Income Quality
 0.18 -2.58 0.28 0.73 0.58
Currency in CNY